Lilly recently revised its revenue forecast for 2024 after seeing weaker-than-expected growth for Zepbound and diabetes brand ...

Lilly recently revised its revenue forecast for 2024 after seeing weaker-than-expected growth for Zepbound and diabetes brand ...

Ten out of 11 children with a form of congenital deafness who were treated with an experimental gene therapy developed by ...

For any company developing AI-powered solutions, the “why” should guide every decision. The technical sophistication of your ...

In a move that will raise eyebrows in Washington, Pfizer has hired the former director of the FDA's Centre for Drug ...

How intelligent technologies are transforming the biopharma industry’Life-changing interventions that have previously been ...

The MELD Graph tool – developed by a team led by scientists at King's College London (KCL) – could "drastically change" care for around 30,000 people with a particular type of epilepsy in the UK by ...

The FDA has started a priority review of Bristol Myers Squibb's Opdivo and Yervoy as a first-line therapy for patients with a ...

Mirum Pharma's Ctexli has become the first FDA-approved therapy for cerebrotendinous xanthomatosis (CTX), an ultra-rare form ...

Cell therapies are the future of healthcare, why are we struggling to make them at scale?

The end of the official shortage status for semaglutide came as telehealth company Hims & Hers – which has been pushing sales ...

Beqvez was Pfizer's first gene therapy, stemming from an alliance with Spark Therapeutics (now part of Roche) more than a ...